Skip to content

Clinical trials

Non-Muscle Invasive Bladder Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-Muscle Invasive Bladder Neoplasms Country / region: United States Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20083
20101
20114
20122
20131
20143
20154
20165
20172
20185
201910
20206
20218
20229
202314
20248
202511
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting35
Completed30
Active, not recruiting21
Terminated15
Withdrawn4
Not yet recruiting2
Available2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC6
UroGen Pharma Ltd.6
ImmunityBio, Inc.5
CG Oncology, Inc.4
Memorial Sloan Kettering Cancer Center4
Pfizer4
Protara Therapeutics4
Endo USA Inc., a Keenova Therapeutics Company3
Photocure3
Spectrum Pharmaceuticals, Inc3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-Muscle Invasive Bladder Neoplasms111
Urinary Bladder Neoplasms68
Carcinoma, Transitional Cell19
Carcinoma in Situ15
Neoplasms8
Urologic Neoplasms7
Urogenital Neoplasms4
Neoplasm Metastasis3
Urinary Bladder Diseases3
Urologic Diseases3

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.